Plasma Therapy: Do we finally have treatment for Coronavirus? - LIVE HEALTHY


Full Width CSS

May 8, 2020

Plasma Therapy: Do we finally have treatment for Coronavirus?

An epidemic called Coronavirus, which has spread its footing across the world today and has proven its dominance. This virus has caught millions of people and is spreading very fast every day. Scientists from all over the world are busy day and night searching for their medicines. They are exploring many angles, including new drugs and compounds daily. Amidst these discoveries, a possible treatment attracted the attention of scientists and doctors from all over the world. This treatment is known as Plasma therapy.

Plasma Therapy: Do we finally have treatment for Coronavirus?

The coronavirus epidemic is believed to have originated in China. They tested this therapy to get rid of COVID-19 patients from this virus. Plasma therapy was initially tested on 15 virus-affected patients, and their condition was seen to improve.
But ICMR does not suggest seeing it as a treatment option based only on clinical trials and with no consistent results. After being severely affected by COVID-19, major countries worldwide, including the United States and the United Kingdom began performing plasma test trials.

What is Plasma Therapy?

Plasma Therapy: Do we finally have treatment for Coronavirus?

Plasma therapy is also known as PRP (platelets rich plasma) therapy. It is a non-surgical treatment to relieve tendon ligament and muscle injuries. Platelets are blood cells that contribute significantly to blood clotting to prevent bleeding. Activated platelets release a variety of growth factors and cellular signaling proteins that are incredibly essential for wound healing. PRP is a type of plasma in which platelets are found in much larger numbers than normal blood plasma.
PRP typically has an increased concentration of these factors by five to ten times. Therefore, it speeds up the healing process. In plasma therapy, a certain amount of blood is drawn from the patient's body. After this different component of blood is separated and concentrated, which is called centrifugation. The fraction of serum that contains platelets is collected and injected at the site of injury.
Since the patient's blood is used in PRP therapy, the risk of injection is minimal. Plasma therapy is beneficial for chronic tendon injuries, especially tennis elbow. However, it proves its effectiveness in treating acute injuries and other conditions. PRP therapy becomes even more popular because it is a low-risk treatment and has the potential to enhance healing.

How does it work?

Our system produces antibodies when our body is engulfed by a novel coronavirus-like pathogen. The immune cell B lymphocytes in the plasma secrete these antibodies. Antibodies are a type of protein that is expanded to identify and characterize intrusive viruses.
Antibodies enable macrophages, a type of white blood cells of the immune system, to prevent the body from being harmed by viruses and bacteria.
Plasma therapy involves harvesting antibodies from a recovered patient and injecting them into a sick person. And in this way, the immune system attacks the intruder virus with the help of antibodies.

What exactly are antibodies?

Antibodies are a frontline immune response that protects your body from microbe infections. They are a special type of protein originating from the immune system's cell B lymphocytes. When our immune system encounters an attacker like a novel coronavirus, it starts releasing antibodies under the immune response. The immune system produces highly specific antibodies based on the characterization and aggressiveness of each invading pathogen. A particular antibody and its partner viruses complement each other and are made to nullify each other.

How is Plasma Therapy given?

In this therapy, blood is drawn from a person who has been cured of COVID-19 infection. The serum is examined and isolated for antibodies that fail the virus. This serum is a blood serum derived from the body of a person recovering from an infectious disease. This serum contains a plethora of unique antibodies to deal with that pathogen. They are then administered into the shape of a patient suffering from the COVID-19 virus. And thus, sick persons get passive immunity.
Before preparing the blood, serum, and testing it on the afflicted person, the potential donor is thoroughly examined. First, the donor's recommended test should be negative and should be completely cured. The recovered person is kept under doctor's observation for 15 days, and the prospective donor must be asymptomatic for at least 28 days.

Challenges for Plasma Therapy

This therapy is not simple to exploit. Primarily, it is difficult to obtain significant amounts of plasma from survivors, especially in diseases such as COVID-19, where most victims are either older or have other medical conditions such as high/low blood pressure, diabetes. Suffer. Therefore, not all cured patients can give voluntarily donate blood.

History of Plasma Therapy

The plasma therapy discovered by the German physiologist Emil von Behring was first tested in 1890. In 1918, this treatment was again used during the Spanish influenza epidemic. In 2009, physicians also used plasma therapy to treat H1N1 disease. In 2014, the World Health Organization (WHO) approved plasma treatment to combat the Ebola virus.

No comments:

Post a Comment

Please do not enter any spam link in the comment box.